Navigation Links
Challenging times for FDA and drug companies equals IT opportunities

Even before the intense scrutiny that started in September when Vioxxs manufacturer removed the drug from the market due to safety concerns, the U.S. Food and Drug Administration and the pharmaceutical industry faced a bumpy road.

One of the biggest challenges has been the pipeline problem, the slowdown instead of the expected acceleration in innovative m......

Full article >>> ing simulation software to improve clinical trial design and predict outcomes.

Better imaging technologies, such as for measuring drug absorption and distribution, may provide powerful insights into the biological effects of pharmaceuticals. But such tools need to be specifically developed and evaluated for drug development. These are but two examples.

Assessing Drug Safety<......

Full article >>> s accepting and investing in bar code technology at a faster rate. Demand for multi-faceted IT systems that improve both productivity and patient safety and well-being will only increase. Facilities already using bar coding will look for enhancements to these systems, and those considering whether and how to adopt bar coding will be evaluating their overall IT needs and options.

Radi......

Full article >>>
'"/>


Source:wistechnology.com By Patricia Kaeding 06/13/05


Related biology technology :

1. Sometimes, features can make a company
2. Venture-backed companies drive job creation, even in tough times
3. A disgusting video: U.S. companies sell out Americans
4. Pre-eminent, web-based companies owe success to corporate venturing
5. Visions: IT exec says CIOs must be ready to help companies ramp up trade
6. Patent licensing: For enforcing companies, the rules have changed
7. Madison firm provides $200K in capital to tech companies
8. Gala Biotech among companies sold for $3.3 billion
9. 2006: A mixed blessing for Midwest life science companies
10. Weather information companies launch data product
11. New firm to help companies land federal dollars
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/23/2017)... March 23, 2017  SeraCare Life Sciences, ... in vitro diagnostics manufacturers and clinical laboratories, ... first multiplexed Inherited Cancer reference material ... by next-generation sequencing (NGS). The Seraseq™ Inherited Cancer ... input from industry experts to validate the ...
(Date:3/23/2017)... ... March 23, 2017 , ... Ellen ... the Connecticut Technology Council (CTC) as a 2017 Women of Innovation® finalist. Matloff ... of Innovation Awards Dinner. , The dinner recognizes women accomplished in science, technology, ...
(Date:3/23/2017)... 2017 According to a report by Transparency ... fragmented due to the presence of a large pool of participants; ... Fisher , and Sigma-Aldrich, compete with each other in this market. ... more than 76% of this market in 2016.  ... As of now, a large number ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... ... monitoring solutions, today announced the hire of Dr. Sigmund “Sig” Floyd as Vice ... applications, strategic partnerships and joint development activities. , “Dr. Floyd’s career has spanned ...
Breaking Biology Technology:
(Date:2/27/2017)... 27, 2017   Strategic Cyber Ventures , the ... led a $3.5 million investment in  Polarity , the ... Ventures is DC based and is led by cybersecurity ... . Ron Gula , also a longtime cybersecurity ... in this series A round of funding. This new ...
(Date:2/21/2017)... , February 21, 2017 ... 70 Millionen US-Dollar wachsen. Nach einem Gespräch mit mehr als ... einige Hindernisse zu überwinden gilt, um diese Prognose zu ... ... anderem die Mobilisierung der finanziellen Mittel für die Biobank, ...
(Date:2/10/2017)... , Feb 10, 2017 Research ... report "Personalized Medicine - Scientific and Commercial Aspects" ... ... medicine. Diagnosis is integrated with therapy for selection of treatment ... early detection and prevention of disease in modern medicine. Biochip/microarray ...
Breaking Biology News(10 mins):